| Bioactivity | IRAK inhibitor 3 is an interleukin-1 (IL-I) receptor-associated kinase (IRAK) kinase modulator extracted from patent WO2008030579 A2. | ||||||||||||
| Target | IRAK | ||||||||||||
| Invitro | IRAK inhibitor 3 is an IRAK modulator, which can be used for treating an inflammatory condition, cell proliferative disorder, immune disorder[1]. | ||||||||||||
| Name | IRAK inhibitor 3 | ||||||||||||
| CAS | 1012343-93-9 | ||||||||||||
| Formula | C21H21N5O4S | ||||||||||||
| Molar Mass | 439.49 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Thomas Durand-Reville, et al. Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder. WO 2008030579 A2. |
IRAK inhibitor 3
CAS: 1012343-93-9 F: C21H21N5O4S W: 439.49
IRAK inhibitor 3 is an interleukin-1 (IL-I) receptor-associated kinase (IRAK) kinase modulator extracted from patent WO2
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.